AI assistant
ProPhase Labs, Inc. — Director's Dealing 2015
Nov 25, 2015
34999_dirs_2015-11-25_73ce282b-8203-40f4-9da5-224e75cd771f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2015-11-24
Reporting Person: Leventhal Mark S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-24 | Common Stock, par value $0.0005 | A | 18500 | $1.30 | Acquired | 850480 | Direct |
| 2015-11-25 | Common Stock, par value $0.0005 | A | 17252 | $1.30 | Acquired | 867732 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.0005 | 180000 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.34, inclusive.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.33, inclusive.
F3: The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.